Patra, T., Meyer, K., Ray, R. B., Kanda, T., & Ray, R. (2021). Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells. Nature Publishing Group.
Chicago Style (17th ed.) CitationPatra, Tapas, Keith Meyer, Ratna B. Ray, Tatsuo Kanda, and Ranjit Ray. Akt Inhibitor Augments Anti-proliferative Efficacy of a Dual MTORC1/2 Inhibitor by FOXO3a Activation in P53 Mutated Hepatocarcinoma Cells. Nature Publishing Group, 2021.
MLA (8th ed.) CitationPatra, Tapas, et al. Akt Inhibitor Augments Anti-proliferative Efficacy of a Dual MTORC1/2 Inhibitor by FOXO3a Activation in P53 Mutated Hepatocarcinoma Cells. Nature Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.